Last reviewed · How we verify

NCT03079752

The Prenatal/Early Infancy Project: An Adolescent Follow-up

Completed NA Last updated 15 March 2017
What this trial tests

NA trial testing Developmental Screening in Behavior, Adaptive in 629 participants. Completed in 30 April 1998.

Timeline
18 March 1994
Primary endpoint
12 September 1996
30 April 1998

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment629
Start date18 March 1994
Primary completion12 September 1996
Estimated completion30 April 1998

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

15 and older, any sex, with Behavior, Adaptive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Nurse-Family Partnership, a program of prenatal and infancy home visiting by nurses, has been examined in a series of 3 randomized trials since 1977. It has received considerable attention in the scientific and public policy communities for its replicated effects on a variety of maternal and child health outcomes across these 3 trials, including prenatal health, childhood injuries, rates of subsequent pregnancies, inter-birth intervals, as well as its long-term effects on maternal life-course, criminal behavior, and 15-year-olds' criminal and antisocial behavior in the first trial of the program conducted in Elmira, New York.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03079752.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing